Order Article Reprints

Grignano MA, Gregorini M, Barisione C, Ivaldo C, Verzola D, Rumeo N, Malabarba S, Mimmi MC, Montatixe Fonseca EC, Viglio S, et al. A Pre-Clinical Study on the Use of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor PEP 2-8 to Mitigate Ischemic Injury in a Rat Marginal Donor Model. International Journal of Molecular Sciences. 2025; 26(18):8937. https://doi.org/10.3390/ijms26188937

Grignano, Maria Antonietta, Marilena Gregorini, Chiara Barisione, Caterina Ivaldo, Daniela Verzola, Noemi Rumeo, Stefano Malabarba, Maria Chiara Mimmi, Elizabeth Carolina Montatixe Fonseca, Simona Viglio, and et al. 2025. "A Pre-Clinical Study on the Use of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor PEP 2-8 to Mitigate Ischemic Injury in a Rat Marginal Donor Model" International Journal of Molecular Sciences 26, no. 18: 8937. https://doi.org/10.3390/ijms26188937

Grignano, M. A., Gregorini, M., Barisione, C., Ivaldo, C., Verzola, D., Rumeo, N., Malabarba, S., Mimmi, M. C., Montatixe Fonseca, E. C., Viglio, S., Iadarola, P., Islami, T., Pattonieri, E. F., Ceccarelli, G., Picciotto, D., Pratesi, G., Viazzi, F., Stea, E. D., Arbustini, E., ... Rampino, T. (2025). A Pre-Clinical Study on the Use of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor PEP 2-8 to Mitigate Ischemic Injury in a Rat Marginal Donor Model. International Journal of Molecular Sciences, 26(18), 8937. https://doi.org/10.3390/ijms26188937